Home ERDERA Clinical Trial Call – Guidelines for Applicants

ERDERA Clinical Trial Call – Guidelines for Applicants

1:1

These guidelines explain the eligibility rules, submission process and Expression of Interest requirements for the ERDERA Clinical Trial Call.

This document sets out the aim, eligibility criteria, application process, and application instructions for the ERDERA Clinical Trial Call (ECTC). It also explains the sections required for the Expression of Interest, including project data, project description, the coordinating investigator and sponsor, partners, budget, notes, declarations, submission and data protection.

publication

Year of publication

2026

Author

European Rare Diseases Research Alliance (ERDERA)

ATMPs (Advanced Therapy Medicinal Products) Basket Trials Clinical Development Clinical Research Networks (CRNs) Clinical Trials Data Collection and Sharing Drug Repurposing ERDERA Clinical Trial Call Genome/exome reanalysis Real-World Data (RWD)

Clinical Research ERDERA Funding International Alignment

Cyprus conference connects European research priorities with the path to rare disease treatments

10 August 2026

At the “Advancement of Treatments for Rare Diseases” conference in Nicosia, European and national policymakers joined clinicians, researchers, regulators, industry representatives and patient advocates to examine how stronger coordination can translate scientific progress into better prevention, diagnosis, treatment and access to care for people living with rare diseases.